Pfizer Inc. (PFE): A Bull Case Theory

We came across a bullish thesis on Pfizer Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.'s share was trading at $25.86 as of January 28th. PFE’s trailing and forward P/E were 15.41 and 9.14, respectively according to Yahoo Finance.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. PFE has strengthened its oncology leadership through the $43 billion acquisition of Seagen in 2023, significantly...